Strongbridge Biopharma plc (SBBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Strongbridge Biopharma plc (SBBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Strongbridge Biopharma plc (SBBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Strongbridge Biopharma plc (SBBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
34 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Strongbridge Biopharma plc (Strongbridge), formerly known as Cortendo plc, is a biopharmaceutical company that offers development, in-licensing, acquisition and eventual commercialization of complementary product across multiple franchises that target rare diseases. The companys pipeline products include COR-003, a cortisol synthesis inhibitor is 2S and 4R-enantiomer of ketoconazole; COR-004, an antisense oligonucleotide; and COR-005, a novel somatostatin analog. Strongbridges primary emphasis is to build franchise around rare endocrine disorders including product candidates for the treatment of endogenous cushings syndrome and acromegaly.

Strongbridge Biopharma plc (SBBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detaile

  
Source:
Document ID
GDPH132607D
Country
Industry
Ticker
SBBP=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Strongbridge Biopharma plc , Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Strongbridge Biopharma plc , Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Strongbridge Biopharma plc , Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Strongbridge Biopharma plc , Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Strongbridge Biopharma plc , Medical Devices Deals, 2010 to YTD 201691
Strongbridge Biopharma plc , Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Strongbridge Biopharma plc , Pharmaceuticals &Healthcare, Deal Details1219
  Asset Purchase121
    Strongbridge Biopharma Acquires Somatoprim from Aspireo Pharma122
  Licensing Agreements141
    Strongbridge Biopharma Terminates Licensing Agreement with Antisense Therapeutics for COR-004142
    Cortendo Enters into Licensing Agreement with Antisense Therapeutics162
  Equity Offering181
    Strongbridge Biopharma Raises USD25 Million in IPO182
    Cortendo Raises USD33.2 Million in Private Placement of Shares201
    Cortendo to Raise USD33.2 Million in Private Placement of Shares212
    Strongbridge Biopharma Raises USD26.4 Million in Private Placement of Shares231
    Cortendo Raises USD37.5 Million in Private Placement of Shares242
    Cortendo Raises USD11 Million in Private Placement of Shares261
    Cortendo Raises USD12.6 Million in Private Placement of Shares271
    Cortendo Raises USD2.1 Million in Private Placement of Shares281
    Cortendo Raises USD0.7 Million in Private Placement of Shares291
    Cortendo Raises USD3.1 Million in Private Placement of Shares301
Strongbridge Biopharma plc - Key Competitors311
Key Employees321
Locations And Subsidiaries331
  Head Office331
  Other Locations &Subsidiaries331
Appendix341
  Methodology341
  About GlobalData341
  Contact Us341
  Disclaimer341

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Strongbridge Biopharma plc (SBBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Strongbridge-Biopharma-plc-SBBP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24968>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Strongbridge Biopharma plc (SBBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Strongbridge-Biopharma-plc-SBBP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-24968>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research